Results
1 -
10 of
54Heredit??re Transthyretin-Amyloidosen, Der Nervenarzt Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy, Journal of Neurology Long-term treatment of transthyretin familial amyloid polyneuropathy with tafamidis: a clinical and neurophysiological study, Journal of Neurology Transthyretin familial amyloid polyneuropathy: an update, Journal of Neurology Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area, Journal of Neurology Amyloidose des Herzens, Der Pathologe Autonomic involvement in hereditary transthyretin amyloidosis (hATTR amyloidosis), Clinical Autonomic Research Aktuelle Diagnostik und Therapie der wichtigsten systemischen Amyloidosen, Der Nephrologe Epigallocatechin-3-gallate tolerability and impact on survival in a cohort of patients with transthyretin-related cardiac amyloidosis. A single-center retrospective study, Internal and Emergency Medicine Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs, Heart Failure Reviews